Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$990,729
+$272,389 QoQ
Shares Held
826
+5.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#3,151
of 4,605 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sepio Capital, LP holds $43,754,387 across 7 Drug Manufacturers - General names. LLY ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
130,177 | $32,757,740 | |
| 2 | JNJ |
Johnson & Johnson
|
20,642 | $5,242,448 | |
| 3 | NVS |
Novartis AG
|
13,731 | $2,151,922 | |
| 4 | NVO |
Novo Nordisk A S
|
36,095 | $1,730,394 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
826 | $990,729 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,766 | $483,931 | |
| 7 | PFE |
Pfizer Inc
|
16,496 | $397,223 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $990,729 | 826 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $718,340 | 781 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $908,104 | 845 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $540,967 | 709 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $255,150 | 288 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $291,460 | 500 | Shares | Sole | 2024-02-09 | |
| 2022-12-31 | $207,797 | 568 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $225,374 | 697 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $213,019 | 657 | Shares | Sole | 2022-07-26 | |
| No filing history on record for this holder in this stock. | ||||||